Mobile-health Network Solutions PE Ratio 2023-2023 | MNDR

Current and historical p/e ratio for Mobile-health Network Solutions (MNDR) from 2023 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Mobile-health Network Solutions PE ratio as of August 21, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Mobile-health Network Solutions PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-08-21 1.04 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.006B $0.014B
Mobile-health Network Solutions is a telehealth solutions provider principally in Singapore. The company offer users with a range of seamless and hassle-free telehealth solutions, which encompasses teleconsultation services, including the issuance of electronic medical certificates and delivery of medications to user homes, as well as other personalized services such as weight management programs. Mobile-health Network Solutions is based in Singapore.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.412B 59.05
Tempus AI (TEM) United States $12.731B 0.00
Doximity (DOCS) United States $12.055B 53.63
Hims & Hers Health (HIMS) United States $9.805B 80.33
IRhythm Technologies (IRTC) United States $5.243B 0.00
Hinge Health (HNGE) United States $4.466B 0.00
Inspire Medical Systems (INSP) United States $2.752B 40.46
Privia Health (PRVA) United States $2.596B 192.27
Heartflow (HTFL) $2.379B 0.00
Enovis (ENOV) United States $1.715B 9.06
10x Genomics (TXG) United States $1.663B 0.00
Phreesia (PHR) United States $1.648B 0.00
Omnicell (OMCL) United States $1.458B 28.10
Schrodinger (SDGR) United States $1.425B 0.00
Azenta (AZTA) United States $1.365B 59.54
Clover Health Investments (CLOV) United States $1.302B 0.00
Claritev (CTEV) United States $1.088B 0.00
Evolent Health (EVH) United States $1.052B 0.00
Fulgent Genetics (FLGT) United States $0.654B 0.00
Zepp Health (ZEPP) Netherlands $0.568B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.470B 0.00
Talkspace (TALK) United States $0.430B 128.50
Butterfly Network (BFLY) United States $0.355B 0.00
Carlsmed (CARL) United States $0.320B 0.00
TruBridge (TBRG) United States $0.291B 51.03
SOPHiA GENETICS SA (SOPH) Switzerland $0.242B 0.00
Outset Medical (OM) United States $0.237B 0.00
Nyxoah SA (NYXH) Belgium $0.216B 0.00
Health Catalyst (HCAT) United States $0.205B 0.00
KORU Medical Systems (KRMD) United States $0.192B 0.00
CapsoVision (CV) United States $0.184B 0.00
MDxHealth SA (MDXH) Belgium $0.139B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.133B 0.00
CareCloud (CCLD) United States $0.112B 5.08
American Well (AMWL) United States $0.111B 0.00
EUDA Health Holdings (EUDA) Singapore $0.077B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
111 (YI) China $0.063B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.039B 0.00
Precipio (PRPO) United States $0.024B 0.00
Zhongchao (ZCMD) China $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00